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Abstract
Background: To study the factors predictive for seizure control in non-ketotic hyperglycemic
induced seizures (NKHS).
Methods: We studied 21 patients who were clinically diagnosed as NKHS at Khon Kaen
University hospital, Thailand. Multiple linear regression analysis was used to identify the factors
predictive for seizure control.
Results: Most patients had no previous history of diabetes and presented with repetitive partial
seizures. The mean number of seizure attacks was 45 times prior to admission. The average
duration to terminate seizure was 36 hours and significantly predicted by frequency of seizures
(estimate 0.9, p value 0.013).
Conclusion: Frequency of seizures is the only predictive factor for the success of seizure control
in NKHS.
Background
Focal seizures can arise for various reasons; including
non-ketotic hyperglycemic seizures (NKHS). NKHS has
been firstly reported by James et al in 1969 [1] and
defined as seizures concurrent with hyperglycemia with-
out any other apparent causes such as brain infarction or
sepsis [2-4]. Tiamkao et al have purposed the diagnostic
clinical criteria in 2003 [5]. The cut-off point for plasma
glucose and plasma osmolarity were more than 290 mg%
and 288 mOsm/kg, respectively.
The common presenting symptom of NKHS is repetitive
focal seizures. Recognition and awareness of this condi-
tion are crucial because the diagnosis is a guide for man-
agement of seizures. NKHS is usually resistant to
anticonvulsant therapy. Phenytoin may even aggravate
seizures [6]. Recently, there is no treatment guideline for
this condition. Either subcutaneous or intravenous insu-
lin without anti-epileptic medication was shown to be
effective [5]. Even though NKHS is not a fatal condition or
causes unconsciousness, it is repetitive, bothersome, and
hard to control. This investigation studied the factors pre-
dictive for seizure control in NKHS. Research has not
found that this issue has been previously reported in the
literature.
Published: 14 December 2009
BMC Neurology 2009, 9:61 doi:10.1186/1471-2377-9-61
Received: 1 May 2009
Accepted: 14 December 2009
This article is available from: http://www.biomedcentral.com/1471-2377/9/61
© 2009 Tiamkao et al; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.Page 1 of 4
(page number not for citation purposes)
BMC Neurology 2009, 9:61 http://www.biomedcentral.com/1471-2377/9/61Methods
Study population
A retrospective study was done at Srinagarind hospital,
Khon Kaen University, Thailand. We searched the hospital
database by using keywords seizure/seizures, epilepsy,
convulsion, hyperglycemia, diabetes mellitus, and hyper-
glycemic seizure for all admitted patients between January
1, 1993 and December 31, 2003. Only patients with an
age of more than 15 years old and met with our criteria
were studied.
The clinical criteria for NKHS [5] were seizures presenting
with plasma glucose more than 290 mg/dL, serum osmo-
larity more than 288 mOsm/L, seizure stopped after
blood sugar and serum osmolarity declined below the
level mentioned above, and the negative study of brain
computed tomography (CT) scan.
According to the previously reported diagnostic criteria [2-
4], cases were excluded if they had a seizure concurrent
with sepsis, septic shock, central nervous system infection,
septic encephalopathy, or other metabolic encephalopa-
thy such as uremic encephalopathy, hepatic encephalopa-
thy, hypo/hyperphosphatemia, hypo/hypercalcemia,
hypo/hypermagnesemia and hypoglycemia.
We collected data from patient records including age, sex,
history of diabetes mellitus, type and location of seizure,
time from seizure onset to admission, frequency of seizure
attacks, initial plasma glucose and serum osmolarity, and
time to seizure control. Type of seizure was clinically
defined as partial or generalized seizure. Frequency of sei-
zure attacks were applied for one who had repetitive sei-
zures and defined by total numbers of seizure clusters
prior to admission. Time to seizure control was defined by
duration between treatment and seizure termination.
Statistical analysis
Descriptive statistics were used to show the patients' base-
line characteristics. Covariates were fitted to find the cor-
relation with time to seizure control by univariate and
multivariate linear regression analysis. The final multiple
linear regression model was identified by using the best
subset selection model method with the lowest Akaike's
information criterion value.
Ethical approval
The study protocol was approved by the institutional
review board and the ethics committee of Khon Kaen Uni-
versity.
Results
There were 54 potential patients in the hospital database
during the mentioned period; only 21 patients were met
with the criteria. The other 33 patients were excluded by
various exclusion criteria (15 patients had no brain imag-
ing, 11 patients had abnormal brain imaging; ten patients
had cerebral infarction and one patient had encephalo-
malacia, 6 patients had plasma glucose less than 290 mg/
dL or serum osmolarity less than 288 mOsm/L, and 1
patient was sepsis).
Out of 21 patients, 11 were male. The median age was 61
year old (range 34-83). Thirteen patients (61.9%) had no
previous history of diabetes and none of them had epi-
lepsy as an underlying disease. Partial seizure was the
most common presenting seizure type in 17 patients (epi-
lepsia partialis continua in 16 patients and complex par-
tial seizure in 1 patient). The other four patients had
generalized tonic clonic seizure. The most common site of
partial seizure was the left hand or left upper extremity
(11 patients).
In average, the patients had seizure attacks 45 times prior
to admission and took 5 days to reach hospital in a range
6-336 hours. The mean initial plasma glucose and serum
osmolarity was 532.9 mg/dL and 302.1 mOsm/L. The
mean (S.D.) duration to seizure control was 36 (36)
hours; data available in 15 patients. The mean (S.D.) post-
ictal plasma glucose was 190.3 (110.4) mg/dL, range 20-
436.
The significant factors that were correlated to time to sei-
zure control by univariate linear regression analysis were
time prior to admission and frequency of seizure attacks
(Table 1). In the final model of multivariate linear regres-
sion, frequency of seizures was the only significant factor
related to time to seizure control (estimate 0.9, p value
0.013). The correlation between time to seizure control
and time to admission was shown in figure 1.
All patients received no prior treatment. The seizure epi-
sodes were initially controlled with subcutaneous regular
insulin or continuous administration then later changed
to oral hypoglycemic agents or subcutaneous insulin. All
of the seizures were successfully controlled by strict con-
trol of blood sugar. One patient developed hypoglycemia
during insulin therapy. None the patients needed long-
term antiepileptic medication and no mortality was
detected. After five years follow-up, none of the patients
developed NKHS again.
Discussion
NKHS is a rare diabetic complication. The most common
presenting symptom is repetitive seizures caused by severe
hyperglycemia. Similar to hyperglycemic hyperosmolar
state, an emergency diabetic complication, NKHS patients
have severe hyperglycemia with hyperosmolarity. There
are, however, some different features.
Hyperglycemic hyperosmolar state may deteriorate
patients' consciousness [7] and usually occurs in estab-Page 2 of 4
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NKHS patients (61.9%) had never been diagnosed as hav-
ing diabetes mellitus and those with partial seizure attacks
retained their consciousness. Some certain precipitating
factors such as serious infection or cardiovascular events
evoke hyperglycemic hyperosmolar state. NKHS in our
series, on the other hand, happened in naïve diabetic
patients without any obvious precipitating factors. If,
however, NKHS is disregarded by patients or diagnosis is
missed or delayed, the episode might turn to hyperglyc-
emic hyperosmolar state.
Seizures as the presenting symptom of NKHS are intermit-
tent, repetitive and bothersome. Even with insulin treat-
Table 1: Baseline covariates and estimate value for time to seizure control by univariate linear regression analysis in patients with non-
ketotic hyperglycemic induced seizures.
Variables Mean (S.D.) Estimate p value
Age (years) 61 (34-83)* 0.7 0.728
Male gender (N) 11 53.8 0.137
Type of seizure
EPC (N) 16 1
GTC (N) 4 -27.58 0.6171
Time prior to admission (hr) 96 (6-336)* 0.2 0.127
Frequency of seizures (times) 44.9 (52.4) 0.8 0.013
Site of body having seizure
Left side (N) 11 1
Right side (N) 5 -12.8 0.778
Both sides (N) 1 -31.5 0.594
Initial plasma glucose (mg/dL) 532.9 (164.9) -0.02 0.841
Initial serum osmolarity (mOsm/L) 302.1 (8.7) -1.2 0.633
Note: EPC; epilepsia partialis continua, GTC; generalized tonic clonic seizure, * show median (range), N; number.
The correlation between time to seizure control from 15 cases and frequency of seizuresFigure 1
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hours. The longest time to seizure control was 264 hours
or 11 days. NKHS mostly attacks the left upper arm or
hands in 64.7% of patients without disturbance of the
consciousness level. For these reasons, most patients seek
healthcare later than other seizure conditions.
From the present data, frequency of seizures is signifi-
cantly related to time to seizure control. The estimate
value of 0.9 indicated that the addition of one seizure
attack needed one more hour to control seizures. Inter-
mittent focal seizures may be explained by a focal tran-
sient abnormal focal area in the brain [8,9] due to
hyperosmolarity as in hyperglycemic hyperosmolar state.
Gamma amino butyric acid, which has been shown to ele-
vate the seizure threshold, may be low in nonketotic coma
[10].
When compared to our previous report [5], the overall
clinical manifestations are very similar in such parameters
as percentage of partial seizure (95.6 vs. 80.9), affected
body part (both a predominance of the left upper extrem-
ity), percentage of treatment-naïve diabetes mellitus
patients (71.4 vs. 61.9), mean duration of seizure (5 vs.
4.9 days), and initial plasma glucose range 290-1099 vs.
299-979). The first number represents previous study.
Previously, physicians in this hospital usually treated
NKHS with insulin therapy without having a CT scan of
the brain [5]. The results from this study, included only
subjects with the negative CT scan of the brain, showed
comparable clinical manifestations and outcomes. There-
fore, insulin treatment can be initiated without brain
imaging of a limited of CT brain, particularly in Thailand
if clinical manifestations are compatible with our criteria.
If, however, seizures are still uncontrolled even with the
plasma glucose levels less than 200 mg/dL or in elderly
patients, the request for brain imaging is justified. Lower-
ing the plasma glucose usually controls NKHS and no
antiepileptic agent is needed [5,11,12].
There were some limitations in our study. Due to the ret-
rospective design, some information might be lost. A
potential recall bias in our study was the total numbers of
seizure clusters prior to admission. However, we do
believe that the patients should be able to give the approx-
imate numbers of seizure clusters because the seizure
attacks occurred intermittently and the patients were con-
scious during the focal seizure attacks. Sepsis is known as
a contributing factor to high plasma glucose and may lead
to seizure attack. We excluded patients with sepsis due to
the previously purposed diagnostic criteria [2-4]. How-
ever, only one patient with sepsis was excluded in our
study.
Conclusion
Even though most seizure attacks in NKHS are partial sei-
zures and do not cause unconsciousness; they are repeti-
tive, bothersome and sometimes difficult to control. A
higher frequency of seizures prior to treatment is an
important predictive factor for the success of seizure con-
trol. Clinical recognition and prompt insulin therapy are
crucial for a satisfactory outcome in NKHS.
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